Most of the carrier tumors showed negative or weak Ki-67 proliferation marker staining (10/12, 83.3%, P = 0.02, OR 5.26, CI 1.15–24.06), indicating that the variant does not associate with a higher proliferation rate of the tumor cells. Here, MKI67 is linked to neoplasm.